Midgard Science

GeneCentric

Durham, NC, United States genecentric.com

From their website, Nov 2026

Work here? Claim this listing

About

GeneCentric develops gene-expression-based biomarkers and liquid biopsy technologies for precision oncology. It works with biopharma, diagnostics, technology, CRO, and commercial lab partners, with headquarters in Durham, North Carolina. Its products and collaborations focus on extracting expression and subtype information from cfDNA or RNA data.

Services

  • ExpressCT™ Biopharma Solutions

    Gene expression-based products and biomarker development for precision oncology programs.

  • ExpressCT™ liquid biopsy pipeline

    Measures gene expression from sequencing data to support biomarkers across breast cancer subtype, lung histology, pan-cancer prognosis, PDAC molecular subtype, tumor fraction, and tissue of origin.

  • ExpressCT Rewind™

    Analyzes banked CGP or WGS cohort FASTQ files to return expression biomarker results without new samples or a new assay.

  • Prospective integration of ExpressCT™

    Embeds expression biomarkers alongside planned or ongoing studies using the same sequencing data or a custom cfDNA panel.

  • GenomicsNext™ custom cfDNA panel

    A custom cfDNA panel designed to maximize fragmentomic signals for use with ExpressCT™.

  • Tissue RNA algorithm pipeline

    RNA-expression-based tissue signatures for therapy selection and prognosis across six cancer types.

  • PurIST® pancreatic cancer test

    Commercially available test that uses RNA sequencing information to classify PDAC into basal or classical subtype.

  • PurIST® Liquid

    Applies ExpressCT™ fragmentomics to cfDNA sequencing to call classical versus basal-like PDAC subtype from blood.

  • ExpressCT™

    A software layer that measures gene expression from cfDNA sequencing data and adds expression-based biomarkers to routine NGS workflows.

  • GenomicsNext™

    A custom cfDNA panel designed to maximize fragmentomic signals for use with ExpressCT™ in prospective studies.

  • PurIST®

    A commercialized pancreatic cancer subtyping test based on tissue RNA expression profiling.

What to send
FASTQ files from a banked CGP or WGS cohort · a blood draw alone · Sequencing data · Custom cfDNA panel data

Capabilities

Assays and studies
NGS · Gene expression profiling · Liquid biopsy · cfDNA sequencing · RNA sequencing · WGS · WES · FASTQ analysis · Molecular subtyping · Tumor fraction · Tissue of origin · RNA expression profiling
2 moreFragmentomics · Gene expression biomarker analysis
Therapeutic areas
Precision oncology · Breast cancer · Pancreatic cancer · Lung cancer · Solid tumors

Modalities and species

Modalities
ADC · Cell therapy
Species and models
PDAC · Breast cancer · Lung cancer

Industries served

  • Biopharma
  • Diagnostics
  • Technology
  • CRO
  • Commercial labs

Company

Founded
2005
Ownership
Small business, as registered with SAM.gov or stated on their site

Locations

Address
6 Davis Dr. Suite 146 Durham, NC 27709
Sites
Durham, United States

Contacts

Similar labs

Work here? Claim this listing